{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:51:41Z","timestamp":1768092701242,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12032-015-0564-4","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T08:05:07Z","timestamp":1426493107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR\/Akt\/NF-\u03baB pathway"],"prefix":"10.1007","volume":"32","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"564_CR1","first-page":"421","volume":"4","author":"E Safarzadeh","year":"2014","unstructured":"Safarzadeh E, Sandoghchian Shotorbani S, Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull. 2014;4:421\u20137.","journal-title":"Adv Pharm Bull"},{"key":"564_CR2","first-page":"2196","volume":"58","author":"BZ Yuan","year":"1998","unstructured":"Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat rhogap. Cancer Res. 1998;58:2196\u20139.","journal-title":"Cancer Res"},{"key":"564_CR3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biocel.2007.04.008","volume":"40","author":"YC Liao","year":"2008","unstructured":"Liao YC, Lo SH. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J Biochem Cell Biol. 2008;40:843\u20137.","journal-title":"Int J Biochem Cell Biol"},{"key":"564_CR4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1582-4934.2007.00098.x","volume":"11","author":"ME Durkin","year":"2007","unstructured":"Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS, Popescu NC. DLC-1: a rho gtpase-activating protein and tumour suppressor. J Cell Mol Med. 2007;11:1185\u2013207.","journal-title":"J Cell Mol Med"},{"key":"564_CR5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3892\/ijo.2013.1885","volume":"42","author":"X Feng","year":"2013","unstructured":"Feng X, Li C, Liu W, Chen H, Zhou W, Wang L, Zhu B, Yao K, Jiang X, Ren C. DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells. Int J Oncol. 2013;42:1973\u201384.","journal-title":"Int J Oncol"},{"key":"564_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1745-7270.2006.00164.x","volume":"38","author":"D Peng","year":"2006","unstructured":"Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H, Yao KT. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin. 2006;38:349\u201355.","journal-title":"Acta Biochim Biophys Sin"},{"key":"564_CR7","doi-asserted-by":"crossref","first-page":"17129","DOI":"10.1073\/pnas.1112122108","volume":"108","author":"G Li","year":"2011","unstructured":"Li G, Du X, Vass WC, Papageorge AG, Lowy DR, Qian X. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an ld-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci USA. 2011;108:17129\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"564_CR8","doi-asserted-by":"crossref","first-page":"e21965","DOI":"10.1371\/journal.pone.0021965","volume":"6","author":"K Dai","year":"2011","unstructured":"Dai K, Liao S, Zhang J, Zhang X, Tu X. Solution structure of tensin2 SH2 domain and its phosphotyrosine-independent interaction with DLC-1. PLoS One. 2011;6:e21965.","journal-title":"PLoS One"},{"key":"564_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.95.1.333","volume":"95","author":"G Greenburg","year":"1982","unstructured":"Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol. 1982;95:333\u20139.","journal-title":"J Cell Biol"},{"key":"564_CR10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"564_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2001-1326-3-17","volume":"3","author":"K Steinestel","year":"2014","unstructured":"Steinestel K, Eder S, Schrader AJ, Steinestel J. Clinical significance of epithelial\u2013mesenchymal transition. Clin Transl Med. 2014;3:17.","journal-title":"Clin Transl Med"},{"key":"564_CR12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial\u2013mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"564_CR13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mc.22044","volume":"53","author":"X Feng","year":"2014","unstructured":"Feng X, Ren C, Zhou W, Liu W, Zeng L, Li G, Wang L, Li M, Zhu B, Yao K, Jiang X. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma. Mol Carcinog. 2014;53:858\u201370.","journal-title":"Mol Carcinog"},{"key":"564_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/gte.2007.0121","volume":"12","author":"XL Feng","year":"2008","unstructured":"Feng XL, Zhou W, Li H, Fang WY, Zhou YB, Yao KT, Ren CP. The DLC-1 -29a\/t polymorphism is not associated with nasopharyngeal carcinoma risk in chinese population. Genet Test. 2008;12:345\u20139.","journal-title":"Genet Test"},{"key":"564_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-12-53","volume":"12","author":"W Zhou","year":"2013","unstructured":"Zhou W, Feng X, Ren C, Jiang X, Liu W, Huang W, Liu Z, Li Z, Zeng L, Wang L, Zhu B, Shi J, Liu J, Zhang C, Liu Y, Yao K. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma. Mol Cancer. 2013;12:53.","journal-title":"Mol Cancer"},{"key":"564_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/14728220903460340","volume":"14","author":"J Schwock","year":"2010","unstructured":"Schwock J, Dhani N, Hedley DW. Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opin Ther Targets. 2010;14:77\u201394.","journal-title":"Expert Opin Ther Targets"},{"key":"564_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"E Deryugina","year":"2006","unstructured":"Deryugina E, Quigley J. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25:9\u201334.","journal-title":"Cancer Metastasis Rev"},{"key":"564_CR18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679\u201395.","journal-title":"Cell"},{"key":"564_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/B978-0-12-800177-6.00005-0","volume":"313","author":"BP Ceresa","year":"2014","unstructured":"Ceresa BP, Peterson JL. Cell and molecular biology of epidermal growth factor receptor. Int Rev Cell Mol Biol. 2014;313:145\u201378.","journal-title":"Int Rev Cell Mol Biol"},{"key":"564_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","volume":"79","author":"R Roskoski Jr","year":"2014","unstructured":"Roskoski R Jr. The erbb\/her family of protein\u2013tyrosine kinases and cancer. Pharmacol Res. 2014;79:34\u201374.","journal-title":"Pharmacol Res"},{"key":"564_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1615\/CritRevOncog.2014011802","volume":"19","author":"L Ombrato","year":"2014","unstructured":"Ombrato L, Malanchi I. The emt universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog. 2014;19:349\u201361.","journal-title":"Crit Rev Oncog"},{"key":"564_CR22","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1007\/s13277-014-2421-z","volume":"35","author":"AM Alizadeh","year":"2014","unstructured":"Alizadeh AM, Shiri S, Farsinejad S. Metastasis review: from bench to bedside. Tumour Biol. 2014;35:8483\u2013523.","journal-title":"Tumour Biol"},{"key":"564_CR23","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1101\/gad.225334.113","volume":"27","author":"JH Tsai","year":"2013","unstructured":"Tsai JH, Yang J. Epithelial\u2013mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192\u2013206.","journal-title":"Genes Dev"},{"key":"564_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.","journal-title":"J Exp Clin Cancer Res"},{"key":"564_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrc2663","volume":"9","author":"TG Cotter","year":"2009","unstructured":"Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer. 2009;9:501\u20137.","journal-title":"Nat Rev Cancer"},{"key":"564_CR26","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3892\/or.2014.3057","volume":"31","author":"C Wang","year":"2014","unstructured":"Wang C, Wang J, Liu H, Fu Z. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the wnt\/beta-catenin signaling pathway. Oncol Rep. 2014;31:2270\u20138.","journal-title":"Oncol Rep"},{"key":"564_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.03.025","volume":"283","author":"T Zhang","year":"2009","unstructured":"Zhang T, Zheng J, Jiang N, Wang G, Shi Q, Liu C, Lu Y. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Cancer Lett. 2009;283:59\u201367.","journal-title":"Cancer Lett"},{"key":"564_CR28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.onc.1207246","volume":"23","author":"X Zhou","year":"2004","unstructured":"Zhou X, Thorgeirsson SS, Popescu NC. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene. 2004;23:1308\u201313.","journal-title":"Oncogene"},{"key":"564_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84\u20139.","journal-title":"Nat Cell Biol"},{"key":"564_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls epithelial\u2013mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76\u201383.","journal-title":"Nat Cell Biol"},{"key":"564_CR31","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1172\/JCI71812","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Lei R, Zhuang X, Zhang N, Pan H, Li G, Hu J, Pan X, Tao Q, Fu D, Xiao J, Chin YE, Kang Y, Yang Q, Hu G. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis. J Clin Investig. 2014;124:1646\u201359.","journal-title":"J Clin Investig"},{"key":"564_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10555-008-9167-2","volume":"28","author":"TY Kim","year":"2009","unstructured":"Kim TY, Vigil D, Der CJ, Juliano RL. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev. 2009;28:77\u201383.","journal-title":"Cancer Metastasis Rev"},{"key":"564_CR33","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial\u2013mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Investig. 2009;119:1438\u201349.","journal-title":"J Clin Investig"},{"key":"564_CR34","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1387\/ijdb.072410mn","volume":"53","author":"MA Nieto","year":"2009","unstructured":"Nieto MA. Epithelial\u2013mesenchymal transitions in development and disease: old views and new perspectives. Int J Dev Biol. 2009;53:1541\u20137.","journal-title":"Int J Dev Biol"},{"key":"564_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2014.10.001","volume":"146","author":"BY Lee","year":"2014","unstructured":"Lee BY, Timpson P, Horvath LG, Daly RJ. Fak signaling in human cancer as a target for therapeutics. Pharmacol Ther. 2014;146:132\u201349.","journal-title":"Pharmacol Ther"},{"key":"564_CR36","doi-asserted-by":"crossref","first-page":"34713","DOI":"10.1074\/jbc.M109.059592","volume":"284","author":"EH Hall","year":"2009","unstructured":"Hall EH, Daugherty AE, Choi CK, Horwitz AF, Brautigan DL. Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion. J Biol Chem. 2009;284:34713\u201322.","journal-title":"J Biol Chem"},{"key":"564_CR37","doi-asserted-by":"crossref","first-page":"a011908","DOI":"10.1101\/cshperspect.a011908","volume":"4","author":"P Nistico","year":"2012","unstructured":"Nistico P, Bissell MJ, Radisky DC. Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol. 2012;4:a011908.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"564_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature03688","volume":"436","author":"DC Radisky","year":"2005","unstructured":"Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 2005;436:123\u20137.","journal-title":"Nature"},{"key":"564_CR39","first-page":"192","volume":"10","author":"GG Gomez","year":"2013","unstructured":"Gomez GG, Wykosky J, Zanca C, Furnari FB, Cavenee WK. Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biol Med. 2013;10:192\u2013205.","journal-title":"Cancer Biol Med"},{"key":"564_CR40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.resinv.2014.10.002","volume":"52","author":"S Takeuchi","year":"2014","unstructured":"Takeuchi S, Yano S. Clinical significance of epidermal growth factor receptor tyrosine kinase inhibitors: sensitivity and resistance. Respir Investig. 2014;52:348\u201356.","journal-title":"Respir Investig"},{"key":"564_CR41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pros.22787","volume":"74","author":"C Wang","year":"2014","unstructured":"Wang C, Wang L, Su B, Lu N, Song J, Yang X, Fu W, Tan W, Han B. Serine protease inhibitor Kazal type 1 promotes epithelial\u2013mesenchymal transition through EGFR signaling pathway in prostate cancer. Prostate. 2014;74:689\u2013701.","journal-title":"Prostate"},{"key":"564_CR42","doi-asserted-by":"crossref","unstructured":"Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR\/Akt\/ikappabbeta\/NF-kappab pathway. Liver Int. 2014.","DOI":"10.1111\/liv.12644"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-015-0564-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0564-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T21:27:55Z","timestamp":1566422875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-015-0564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s12032-015-0564-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]},"article-number":"115"}}